|
|
 |
|
| | |
| | | | | | |
modification
|
|
PR:000018518 |
inhibin alpha chain proteolytic cleavage product
|
INHA/ClvPrd
|
"An inhibin alpha chain that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | |
modification
|
|
PR:000001732 |
inhibin alpha chain isoform 1 cleaved and glycosylated form
|
INHA/iso:1/ClvGlyco+
|
"An inhibin alpha chain isoform 1, signal peptide removed form that has been processed by proteolytic cleavage and includes at least one glycosylated residue." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | |
modification
|
|
PR:000001733 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2
|
INHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been glycosylated at Asn residues within the two consensus glycosylation sites. Glycosylation favors formation of the inhibin A complex. Example: UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240]
|
|
|
|
|
|
|
| | | | | | | | |
|
organism-modification
|
|
PR:000036608 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human)
|
hINHA/iso:1/ClvNGlyco:2
|
"An inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 in human. UniProtKB:P05111-1, 233-366, Asn-268/Asn-302, MOD:00160." [PMID:17456790, PMID:8885240, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
modification
|
|
PR:000001736 |
inhibin alpha chain isoform 1 cleaved and N-glycosylated 1
|
INHA/iso:1/ClvNGlyco:1
|
"An inhibin alpha chain isoform 1 cleaved and glycosylated form that has had release of the propeptide and has been N-glycosylated at an Asn residue within the first (or unique) consensus glycosylation site. Glycosylation favors formation of the inhibin A complex." [PMID:17456790]
|
|
|
|
|
